Evidence map›Paper›PMID 24493923›Full record

ReviewInternational journal of chronic obstructive pulmonary disease2014

Clinical issues of mucus accumulation in COPD.

Frederick L Ramos, Jason S Krahnke, Victor Kim

3 registry-linked trialsAbstract readReview
In one paragraph

Review in International journal of chronic obstructive pulmonary disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 86 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02483637 nacompletednot on this mapstarted 2016, after this paper: background citation

A Prospective Safety and Feasibility Study of the RejuvenAir™ System Metered Cryospray Therapy for Chronic Bronchitis Patients

TypeinterventionalSponsorCSA Medical, Inc.Ran2016 to 2022Enrolled30ConditionsBronchitis, Chronic, Cryotherapy EffectArmsRejuvenAir
NCT05922241 nacompletednot on this mapstarted 2023, after this paper: background citation

Comparative Effects of Costophrenic Assisted Cough and Anterior Chest Compression Technique on Sputum Diary, Oxygen Saturation, Expiratory Flow Rate, and Dyspnea in Patients With Chronic Obstructive Pulmonary Disease

TypeinterventionalSponsorRiphah International UniversityRan2023 to 2023Enrolled34ConditionsChronic Obstructive Pulmonary DiseaseArmsCostophrenic assisted cough, Anterior chest compression
NCT05936801 nacompletednot on this mapstarted 2023, after this paper: background citation

Comparative Effects of Anterior Chest Compression Assist and Abdominal Thrust Assist Technique on Sputum Diary, Oxygen Saturation, Expiratory Flow Rate, and Dyspnea in Patients With Chronic Obstructive Pulmonary Disease

TypeinterventionalSponsorRiphah International UniversityRan2023 to 2023Enrolled34ConditionsCOPDArmsAnterior Chest Compression technique, Abdominal Thrust Technique
3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Soft Artificial Ciliary Brush with Integrated Haptic Feedback for Efficient Airway Mucus Cleaning.Advanced intelligent systems (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Frederick L RamosDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA.
Jason S KrahnkeDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA.
Victor KimDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA.

Funding

Th17 inflammation is responsible for mucous metaplasia in COPDK23HL094696 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KIM, VICTOR · 2011 to 2014
$563k
NHLBI NIH HHS K23 HL094696
6 · The paper itself

Abstract

Airway mucus is part of the lung's native immune function that traps particulates and microorganisms, enabling their clearance from the lung by ciliary transport and cough. Mucus hypersecretion and chronic productive cough are the features of the chronic bronchitis and chronic obstructive pulmonary disease (COPD). Overproduction and hypersecretion by goblet cells and the decreased elimination of mucus are the primary mechanisms responsible for excessive mucus in chronic bronchitis. Mucus accumulation in COPD patients affects several important outcomes such as lung function, health-related quality of life, COPD exacerbations, hospitalizations, and mortality. Nonpharmacologic options for the treatment of mucus accumulation in COPD are smoking cessation and physical measures used to promote mucus clearance. Pharmacologic therapies include expectorants, mucolytics, methylxanthines, beta-adrenergic receptor agonists, anticholinergics, glucocorticoids, phosphodiesterase-4 inhibitors, antioxidants, and antibiotics.

Indexed as

Mucociliary ClearanceAnti-Bacterial AgentsBronchitis, ChronicExpectorantsGoblet CellsHumansLungMucusPulmonary Disease, Chronic ObstructiveSmoking CessationTreatment OutcomeAnti-Bacterial AgentsExpectorantschronic bronchitischronic obstructive pulmonary diseasemucussputum

Identifiers

PMID24493923
PMCPMC3908831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.